Table 1: Comparison of clinical data between two groups.
|
Item |
Category |
Polyps group (n = 84) |
Control group (n = 86) |
t/χ2 |
P |
|
Age（years） |
|
39.04 ± 8.11 |
37.95 ± 7.23 |
0.92 |
0.36 |
|
Gravidity
|
≤ 1 time ≥ 2 times |
38 46 |
41 45 |
0.101
|
0.75
|
|
Parity
|
≤ 1 time ≥ 2 times |
59 25 |
62 24 |
0.071
|
0.79
|
|
Menstrual cycle
|
Regular Irregular/Amenorrhea |
58 26 |
68 18 |
2.22
|
0.136
|
|
High blood pressure (mmHg) |
Yes No |
4 80 |
4 82 |
0.108
|
0.74
|
|
BMI (kg/m2) |
|
23.03 ± 3.02 |
21.86 ± 5.41 |
1.786 |
0.076 |
|
FPG (mmol/L) |
|
5.41 ± 0.84 |
5.30 ± 0.69 |
0.936 |
0.351 |
|
FIN (mIU/L) |
|
8.59 ± 2.08 |
7.37 ± 1.96 |
12.43 |
< 0.001 |
|
HOMA-IR |
|
2.01 ± 1.44 |
0.96 ± 0.75 |
6.33 |
|
|
IR prevalence (%) |
|
23.8 (20/84) |
15.1 (13/86) |
2.05 |
< 0.001 0.15 |
|
Endometrial staging |
Proliferative phase Secretory phase |
45 39 |
55 31 |
1.89 |
0.17 |